Banner - Hide this banner
0 Members and 1 Guest are viewing this topic.
I updated my initial post to include microfracture as it does grow scar tissue. Fibrocartilage is essentially scar tissue.
Nice overview, thanks! From a consumer/patient perspective, the "cartilage repair/regrowth" industry is certainly messy.
Also you forgot Denovo NT - minced juvenile allograft cartilage. It is only available in the US and also has proven regrowth of cartilage. It would be interesting to have a comparison study between Autocart and Denovo NT. Main advantage over Autocart is that you have Juvenile Donors, main disadvantages: much more expensive, unknown quality of the cartilage (is it load bearing or non load bearing cartilage - or a mix), not fresh. I kinda think Denovo NT has not proven it is superior to MACI and will never be a largely available product but only a niche product (maybe for older patients).
(Brian Cole now seems to be a strong proponent of Autocart too). It was strongly superior to Microfracure at 12 and 24 months (sadly no 5 year data). With Brian Cole switching from CAIS to Autocart I guess CAIS is dead now.